Key result
Hemodynamic and serum cardiac markers are closely linked with an increased risk of cognitive impairment and accelerated cognitive decline.
Why the study?
Are hemodynamic and serum cardiac markers associated with the risk of cognitive impairment and dementia?
Systematic Review
Are hemodynamic and serum cardiac markers associated with the risk of cognitive impairment and dementia?
Hemodynamic and serum cardiac markers are closely linked with the risk of cognitive impairment, highlighting the importance of the heart-brain connection in dementia risk assessment.
Supports cardiac marker integration into dementia risk models; extends evidence for cardiovascular contributions to cognitive decline.
INTRODUCTION: Cardiac function is a key player in maintaining energy homeostasis in the brain. Heart failure is closely related to higher risk of neurocognitive disorders. Recent evidence shows that this relationship might not be limited to patients with advanced heart failure, and even suboptimal cardiac functioning is associated with accelerated brain aging. Hence, hemodynamic and serum cardiac markers may provide valuable information about the risk of dementia. METHODS: We provide an overview on the link between cardiac markers and cognitive function by a systematic search in five databases. Furthermore, we discuss the pathophysiological aspects of this link and highlight the pertinent clinical and public health implications. RESULTS: Increasing evidence supports the associations of hemodynamic and serum cardiac markers with accelerated cognitive decline. DISCUSSION: Hemodynamic and serum cardiac markers are closely linked with risk of cognitive impairment. This highlights the significance of the heart-brain connection in reducing the burden of dementia.
No takes yet. Share an insight, caveat, or question.
Velpen et al. (2016) conducted a systematic review in Cognitive impairment and dementia. Hemodynamic and serum cardiac markers was evaluated on Risk of cognitive impairment and dementia. Hemodynamic and serum cardiac markers are closely linked with an increased risk of cognitive impairment and accelerated cognitive decline.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: